chr9-133205926-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014581.4(OBP2B):āc.505G>Cā(p.Glu169Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000112 in 1,613,120 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014581.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OBP2B | NM_014581.4 | c.505G>C | p.Glu169Gln | missense_variant | 6/7 | ENST00000372034.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OBP2B | ENST00000372034.8 | c.505G>C | p.Glu169Gln | missense_variant | 6/7 | 1 | NM_014581.4 | P1 | |
OBP2B | ENST00000618116.4 | c.505G>C | p.Glu169Gln | missense_variant | 6/7 | 1 | P1 | ||
OBP2B | ENST00000461961.2 | n.413G>C | non_coding_transcript_exon_variant | 5/6 | 1 | ||||
OBP2B | ENST00000473737.5 | c.*113G>C | 3_prime_UTR_variant, NMD_transcript_variant | 7/8 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 152112Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000155 AC: 39AN: 251116Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135706
GnomAD4 exome AF: 0.000105 AC: 153AN: 1460890Hom.: 0 Cov.: 45 AF XY: 0.0000963 AC XY: 70AN XY: 726778
GnomAD4 genome AF: 0.000177 AC: 27AN: 152230Hom.: 0 Cov.: 35 AF XY: 0.000161 AC XY: 12AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.505G>C (p.E169Q) alteration is located in exon 6 (coding exon 6) of the OBP2B gene. This alteration results from a G to C substitution at nucleotide position 505, causing the glutamic acid (E) at amino acid position 169 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at